Once-Promising Diabetes Drugs’ Side-Effects Can be Limited, Study Finds
Altering the activity of the PPARg receptor could limit the side-effects of a useful group of diabetes drugs, TZDs.
Posts tagged as
Kojetin
Altering the activity of the PPARg receptor could limit the side-effects of a useful group of diabetes drugs, TZDs.